Cabotegravir
| CAS No. | 1051375-10-0 |
|---|---|
| MDL No. | MFCD25976748 |
| MF | C19H17F2N3O5 |
| MW | 405.40 |
| InChI Key | WCWSTNLSLKSJPK-LKFCYVNXSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Cabotegravir is a monocarboxylic acid amide formed by the formal condensation of the carboxy group of (3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid with the amino group of 2,4-difluorobenzylamine. It is used as its sodium salt in the treatment of HIV-1 and functions as a HIV-1 integrase inhibitor. It is a difluorobenzene, a secondary carboxamide, an organic heterotricyclic compound, and a conjugate acid of cabotegravir(1-).
| CAS No. | 1051375-10-0 |
|---|---|
| Product Name | Cabotegravir |
Associated Conditions
HIV-1 infection·HIV-Associated Lipodystrophy Syndrome·viral disease·HIV infection
* The information provided here is compiled from public sources and is for reference only.
